Exclusive

Publication

Byline

Location

US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on July 7 for "Use of inhibitors of the activator protein 1 (AP-1) for preventing adhesions" (California Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,043, issued on July 7, was assigned to The Board of Trustees of the Leland Stanford Junior University. "Use of inhibitors of the activator p... Read More


US Patent Issued to ORYZON GENOMICS on July 7 for "Methods of treating borderline personality disorder" (Spanish, Portuguese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,044, issued on July 7, was assigned to ORYZON GENOMICS S.A. (Madrid). "Methods of treating borderline personality disorder" was invented by ... Read More


US Patent Issued to PREMARK PHARMA on July 7 for "Treatment of ocular disease" (Swiss Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,045, issued on July 7, was assigned to PREMARK PHARMA GMBH (Reinach, Switzerland). "Treatment of ocular disease" was invented by Ian Vessey ... Read More


US Patent Issued to MERCK PATENT, RYVU THERAPEUTICS on July 7 for "Substituted tetrazoles as ACSS2 inhibitors" (German Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,046, issued on July 7, was assigned to MERCK PATENT GMBH (Darmstadt, Germany) and RYVU THERAPEUTICS S.A. (Krawkow, Poland). "Substituted tet... Read More


US Patent Issued to THE GEORGE INSTITUTE FOR GLOBAL HEALTH on July 7 for "Compositions for the treatment of hypertension" (Australian Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,047, issued on July 7, was assigned to THE GEORGE INSTITUTE FOR GLOBAL HEALTH (Randwick, Australia). "Compositions for the treatment of hype... Read More


US Patent Issued to MINORYX THERAPEUTICS on July 7 for "Method of administering a therapeutically effective amount of 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-ylethoxyphenylmethyl-1,3-thiazolidine-2,4-dione" (Spanish, British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,048, issued on July 7, was assigned to MINORYX THERAPEUTICS S.L. (Mataro Barcelona, Spain). "Method of administering a therapeutically effec... Read More


US Patent Issued to SHANGHAI WD PHARMACEUTICAL on July 7 for "Pharmaceutical composition containing dabigatran etexilate and preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,049, issued on July 7, was assigned to SHANGHAI WD PHARMACEUTICAL Co. LTD (Shanghai). "Pharmaceutical composition containing dabigatran etex... Read More


US Patent Issued to CENTESSA PHARMACEUTICALS (UK) on July 7 for "Compositions and their use for the treatment of A1-antitrypsin deficiency" (British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,050, issued on July 7, was assigned to CENTESSA PHARMACEUTICALS (UK) Ltd. (Altrincham, Great Britain). "Compositions and their use for the t... Read More


US Patent Issued to SHENZHEN FIRST UNION TECHNOLOGY, SHENZHEN HERUI BIOTECHNOLOGY on July 7 for "Composition and product thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,051, issued on July 7, was assigned to SHENZHEN FIRST UNION TECHNOLOGY Co. LTD. (Shenzhen City, China) and SHENZHEN HERUI BIOTECHNOLOGY Co. L... Read More


US Patent Issued to Exelixis on July 7 for "Combinations for the treatment of cancer" (California Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,052, issued on July 7, was assigned to Exelixis Inc. (Alameda, Calif.). "Combinations for the treatment of cancer" was invented by Gisela Sc... Read More